Reaction
Calculus Ureteric reporting signals
As of the last recalculation, Calculus Ureteric appears in 725 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is CEFTRIAXONE (PRR 45.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ceftriaxone | 49 | 45.9 | 46.0 |
| Ceftriaxone Sodium | 50 | 40.1 | 40.2 |
| Atazanavir | 19 | 39.0 | 39.0 |
| Ritonavir | 21 | 21.2 | 21.2 |
| Quinapril Hydrochloride | 5 | 18.3 | 18.3 |
| Zonisamide | 9 | 17.7 | 17.7 |
| Etonogestrel And Ethinyl Estradiol | 12 | 15.8 | 15.8 |
| Gefitinib | 3 | 9.6 | 9.6 |
| Isotretinoin | 14 | 8.3 | 8.3 |
| Exenatide | 13 | 7.2 | 7.2 |